These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2532376)

  • 1. Endocrine treatment of prostate cancer.
    Turkes AO; Griffiths K
    Prog Med Chem; 1989; 26():299-321. PubMed ID: 2532376
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
    Moffat LE
    Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272
    [No Abstract]   [Full Text] [Related]  

  • 3. Endocrine therapy for advanced stage D prostate cancer.
    Taylor TK
    Urol Nurs; 1991 Sep; 11(3):22-6. PubMed ID: 1833823
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent developments in endocrine treatment of prostate cancer.
    Vogelzang NJ; Kennealey GT
    Cancer; 1992 Aug; 70(4 Suppl):966-76. PubMed ID: 1386283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma.
    Peeling WB
    Urology; 1989 May; 33(5 Suppl):45-52. PubMed ID: 2523611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F; Dupont A; Belanger A
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract]   [Full Text] [Related]  

  • 7. How should we understand the term androgen deprivation therapy?
    Drewa T; Soloway MS
    Eur Urol; 2012 Apr; 61(4):856. PubMed ID: 22266269
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone therapy of prostatic bone metastases.
    Huben RP
    Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone therapy in prostate cancer: clinical results].
    Morote-Robles J
    Rev Esp Fisiol; 1990 Mar; 46(1):59-62. PubMed ID: 1697693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal treatment of advanced disease: some newer aspects.
    Griffiths K; Eaton CL; Harper ME; Turkes A; Peeling WB
    Semin Oncol; 1994 Oct; 21(5):672-87. PubMed ID: 7939755
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
    Eisenberger MA; O'Dwyer PJ; Friedman MA
    J Clin Oncol; 1986 Mar; 4(3):414-24. PubMed ID: 2936872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximal androgen blockade in prostatic cancer.
    Denis L
    Scand J Urol Nephrol Suppl; 1991; 138():137-44. PubMed ID: 1838427
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison between surgical orchidectomy and the LHRH agonist 'Zoladex' (ICI 188630) in the treatment of metastatic cancer of the prostate.
    Peeling WB
    Prog Clin Biol Res; 1989; 303():41-5. PubMed ID: 2528738
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a best castration?
    Griffiths K
    Cancer; 1993 Dec; 72(12 Suppl):3807-9. PubMed ID: 8252495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, comparative study of buserelin with DES/orchiectomy in the treatment of stage D2 prostatic cancer patients.
    Klioze SS; Miller MF; Spiro TP
    Am J Clin Oncol; 1988; 11 Suppl 2():S176-82. PubMed ID: 3149455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer.
    Schulze H; Kaldenhoff H; Senge T
    Urol Int; 1988; 43(4):193-7. PubMed ID: 2973169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocrine treatment of prostate cancer: standard treatment and new perspectives.
    Boccardo F; Pace M
    In Vivo; 1993; 7(5):423-4. PubMed ID: 8110985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goserelin--another LH-RH analog for prostate cancer.
    Med Lett Drugs Ther; 1990 Nov; 32(830):102. PubMed ID: 1700261
    [No Abstract]   [Full Text] [Related]  

  • 20. Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
    Bouffioux C
    Eur Urol; 1988; 15(3-4):187-92. PubMed ID: 2975222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.